114 related articles for article (PubMed ID: 17587359)
1. Elevated C-reactive protein levels are not a feature of uncomplicated radiation-induced bowel injury.
Khalid U; Norman AR; Andreyev HJ
Eur J Cancer Care (Engl); 2007 Jul; 16(4):346-50. PubMed ID: 17587359
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
3. Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?
Wedlake L; McGough C; Hackett C; Thomas K; Blake P; Harrington K; Tait D; Khoo V; Dearnaley D; Andreyev HJ
Aliment Pharmacol Ther; 2008 May; 27(10):980-7. PubMed ID: 18315578
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
5. The significance of rectal bleeding after pelvic radiotherapy.
Williams HR; Vlavianos P; Blake P; Dearnaley DP; Tait D; Andreyev HJ
Aliment Pharmacol Ther; 2005 May; 21(9):1085-90. PubMed ID: 15854169
[TBL] [Abstract][Full Text] [Related]
6. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men.
Chiu HM; Lin JT; Chen TH; Lee YC; Chiu YH; Liang JT; Shun CT; Wu MS
Am J Gastroenterol; 2008 Sep; 103(9):2317-25. PubMed ID: 18844617
[TBL] [Abstract][Full Text] [Related]
7. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.
Papadia C; Sherwood RA; Kalantzis C; Wallis K; Volta U; Fiorini E; Forbes A
Am J Gastroenterol; 2007 Jul; 102(7):1474-82. PubMed ID: 17459021
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist?
Andreyev HJ; Vlavianos P; Blake P; Dearnaley D; Norman AR; Tait D
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1464-71. PubMed ID: 15927411
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease.
Chamouard P; Richert Z; Meyer N; Rahmi G; Baumann R
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):882-7. PubMed ID: 16630759
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer.
Ki Y; Kim W; Nam J; Kim D; Park D; Kim D
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):393-8. PubMed ID: 19362778
[TBL] [Abstract][Full Text] [Related]
11. The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases.
Vermeire S; Van Assche G; Rutgeerts P
Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):580-6. PubMed ID: 16327837
[TBL] [Abstract][Full Text] [Related]
12. Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients.
Bradbury BD; Critchlow CW; Weir MR; Stewart R; Krishnan M; Hakim RH
Nephrol Dial Transplant; 2009 Mar; 24(3):919-25. PubMed ID: 18840893
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K
BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628
[TBL] [Abstract][Full Text] [Related]
14. The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery disease patients.
Fabijanić D; Banić M; Kardum D; Sutlić Z; Simunić M; Bonacin D; Romić Z; Petricusić L; Kujundzić M
Med Sci Monit; 2009 Feb; 15(2):CR45-50. PubMed ID: 19179966
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
Haim M; Benderly M; Tanne D; Matas Z; Boyko V; Fisman EZ; Tenenbaum A; Zimmlichman R; Battler A; Goldbourt U; Behar S
Am Heart J; 2007 Dec; 154(6):1095-101. PubMed ID: 18035081
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality.
Currie CJ; Poole CD; Conway P
Heart; 2008 Apr; 94(4):457-62. PubMed ID: 17761503
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.
Mojahedi MJ; Bonakdaran S; Hami M; Sheikhian MR; Shakeri MT; Aiatollahi H
Iran J Kidney Dis; 2009 Jan; 3(1):12-6. PubMed ID: 19377253
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of C-reactive protein in long-term care patients requiring prolonged mechanical ventilation.
Sierros V; Fleming R; Cascioli M; Brady T
Chron Respir Dis; 2009; 6(3):149-55. PubMed ID: 19643829
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
20. Determinants of C-reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilization.
Hung A; Pupim L; Yu C; Shintani A; Siew E; Ayus C; Hakim RM; Ikizler TA
Hemodial Int; 2008 Apr; 12(2):236-43. PubMed ID: 18394058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
